FDA Requests Novartis’ IBS Drug Zelnorm Be Taken Off Market Because of Cardiovascular Risk March 30, 2007
Fed-Phen Trial Ordered Over Plaintiff Counsel Ethics Issues in Apportioning Settlement Money March 29, 2007